27916455|t|Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington's Disease Models
27916455|a|Huntington's disease (HD) symptoms are driven to a large extent by dysfunction of the basal ganglia circuitry. HD patients exhibit reduced striatal phoshodiesterase 10 (PDE10) levels. Using HD mouse models that exhibit reduced PDE10, we demonstrate the benefit of pharmacologic PDE10 inhibition to acutely correct basal ganglia circuitry deficits. PDE10 inhibition restored corticostriatal input and boosted cortically driven indirect pathway activity. Cyclic nucleotide signaling is impaired in HD models, and PDE10 loss may represent a homeostatic adaptation to maintain signaling. Elevation of both cAMP and cGMP by PDE10 inhibition was required for rescue. Phosphoproteomic profiling of striatum in response to PDE10 inhibition highlighted plausible neural substrates responsible for the improvement. Early chronic PDE10 inhibition in Q175 mice showed improvements beyond those seen with acute administration after symptom onset, including partial reversal of striatal deregulated transcripts and the prevention of the emergence of HD neurophysiological deficits. VIDEO ABSTRACT.
27916455	0	21	Phosphodiesterase 10A	T116,T126	C1452465
27916455	22	32	Inhibition	T052	C3463820
27916455	42	63	Cortico-Basal Ganglia	T023	C0004781
27916455	64	72	Function	T039	C0031843
27916455	76	96	Huntington's Disease	T047	C0020179
27916455	97	103	Models	T050	C0012644
27916455	104	124	Huntington's disease	T047	C0020179
27916455	126	128	HD	T047	C0020179
27916455	130	138	symptoms	T184	C1457887
27916455	155	167	large extent	T080	C1555602
27916455	171	182	dysfunction	T077	C3887504
27916455	190	203	basal ganglia	T023	C0004781
27916455	204	213	circuitry	T023	C0599854
27916455	215	217	HD	T047	C0020179
27916455	218	226	patients	T101	C0030705
27916455	243	271	striatal phoshodiesterase 10	T116,T126	C1447737
27916455	273	278	PDE10	T116,T126	C1447737
27916455	294	296	HD	T047	C0020179
27916455	297	309	mouse models	T050	C2986594
27916455	331	336	PDE10	T116,T126	C1452465
27916455	357	364	benefit	T081	C0814225
27916455	368	381	pharmacologic	T169	C0205464
27916455	382	387	PDE10	T116,T126	C1452465
27916455	388	398	inhibition	T052	C3463820
27916455	418	431	basal ganglia	T023	C0004781
27916455	432	441	circuitry	T023	C0599854
27916455	442	450	deficits	T080	C2987487
27916455	452	457	PDE10	T116,T126	C1452465
27916455	458	468	inhibition	T052	C3463820
27916455	478	493	corticostriatal	T023	C0229962
27916455	494	499	input	T077	C1708517
27916455	530	538	indirect	T080	C0439852
27916455	539	546	pathway	T077	C1705987
27916455	547	555	activity	T052	C0441655
27916455	557	584	Cyclic nucleotide signaling	T044	C1155588
27916455	588	596	impaired	T169	C0221099
27916455	600	602	HD	T047	C0020179
27916455	603	609	models	T050	C0012644
27916455	615	620	PDE10	T116,T126	C1452465
27916455	642	653	homeostatic	T038	C0019868
27916455	654	664	adaptation	T038	C0392673
27916455	677	686	signaling	T038	C3537152
27916455	688	697	Elevation	T061	C0439775
27916455	706	710	cAMP	T114,T121,T123	C0001455
27916455	715	719	cGMP	T114,T123	C0018338
27916455	723	728	PDE10	T116,T126	C1452465
27916455	729	739	inhibition	T052	C3463820
27916455	765	791	Phosphoproteomic profiling	T059	C1327760
27916455	795	803	striatum	T023	C0229962
27916455	819	824	PDE10	T116,T126	C1452465
27916455	825	835	inhibition	T052	C3463820
27916455	858	864	neural	T169	C3714606
27916455	865	875	substrates	T167	C3891814
27916455	896	907	improvement	T077	C2986411
27916455	915	922	chronic	T079	C0205191
27916455	923	928	PDE10	T116,T126	C1452465
27916455	929	939	inhibition	T052	C3463820
27916455	943	952	Q175 mice	T050	C2986594
27916455	960	972	improvements	T077	C2986411
27916455	996	1001	acute	T079	C0205178
27916455	1002	1016	administration	T061	C1533734
27916455	1023	1030	symptom	T184	C1457887
27916455	1031	1036	onset	T080	C0332162
27916455	1048	1055	partial	T081	C0728938
27916455	1056	1064	reversal	T169	C0443290
27916455	1068	1076	striatal	T023	C0229962
27916455	1077	1088	deregulated	T052	C1880287
27916455	1089	1100	transcripts	T114	C1519595
27916455	1109	1119	prevention	T080	C2700409
27916455	1127	1136	emergence	T052	C1706079
27916455	1140	1142	HD	T047	C0020179
27916455	1143	1161	neurophysiological	T040	C1327471
27916455	1162	1170	deficits	T080	C2987487